Join
Live feed
·
PRReleasevia Quantisnow
Myriad Genetics Inc. logo

Myriad Genetics Expands Availability of Precise MRD™ for Colorectal, Renal and Breast Cancers, Supported by New Publication

ByQuantisnow·Wall Street's wire, on your screen.
MYGN· Myriad Genetics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYGN (Myriad Genetics Inc.) and more on Quantisnow.